AnaptysBio to split into two public companies: one for royalty management, the other for immunology drug development. Read more here.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback